Aurora Medical GroupAurora Baycare Medical Center 2845 Greenbrier Rd, Green Bay, WI 54311 (920)2888000 (phone), (920)2885510 (fax)
Bay Care Clinic Physical Medicine 2845 Greenbrier Rd STE 340, Green Bay, WI 54311 (920)2888377 (phone), (920)2888385 (fax)
Education:
Medical School The Fourth Military Med Univ, Xian City, Shaanxi, China Graduated: 1984
Procedures:
Physical Medicine and Rehabilitation, Tests and Measurements Physical Therapy Physical Therapy Evaluation Arthrocentesis Neurological Testing
Conditions:
Cholelethiasis or Cholecystitis Gastrointestinal Hemorrhage Inguinal Hernia Malignant Neoplasm of Esophagus Varicose Veins
Languages:
Chinese English French Spanish
Description:
Dr. Chen graduated from the The Fourth Military Med Univ, Xian City, Shaanxi, China in 1984. He works in Green Bay, WI and 1 other location and specializes in Physical Medicine & Rehabilitation. Dr. Chen is affiliated with Aurora Baycare Medical Center.
Dr. Chen graduated from the Peking Union Med Coll, Beijing, Beijing, China in 1993. She works in Rego Park, NY and specializes in Pediatrics. Dr. Chen is affiliated with Flushing Hospital Medical Center and Jamaica Hospital Medical Center.
Xin Chen - Hockessin DE, US Howard W. Prokop - Chadds Ford PA, US Stephen Howard Colmery - Newark DE, US
Assignee:
Uniqema Americas LLC - Wilmington DE
International Classification:
C07C 231/00
US Classification:
554 69
Abstract:
The present invention relates to a process for the manufacture of alkanolamide containing compositions, and more particularly to a process of reacting a fatty acid and diethanolamine (DEA) which result in the formation of low levels of undesirable by products, particularly of bis-hydroxyethyl piperazine (BHEP).
Melanocortin Receptor-Specific Peptides For Treatment Of Obesity / 669
Xin Chen - Furlong PA, US Shubh D. Sharma - Cranbury NJ, US Yi-Qun Shi - East Brunswick NJ, US Wei Yang - Edison NJ, US
Assignee:
Palatin Technologies, Inc - Cranbury NJ
International Classification:
A61K 38/12 C07K 7/64 A61P 3/00
US Classification:
514 11, 530321
Abstract:
Melanocortin receptor-specific cyclic peptides of the formulawhere R, R, R, R, x and y are as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including obesity, diabetes, modulation of feeding behavior and related metabolic syndrome.
Xin Chen - Furlong PA, US Wei Yang - Edison NJ, US
Assignee:
PALATIN TECHNOLOGIES, INC. - Cranbury NJ
International Classification:
C07K 7/54
US Classification:
530323
Abstract:
Lactam-bridged melanocortin receptor-specific cyclic peptides of the formulawhere R, R, R, R, R, R, R, Rand Rare as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including obesity, modulation of feeding behavior, related metabolic syndrome, sexual dysfunction, male erectile dysfunction and female sexual dysfunction.
Xin Chen - Hockessin DE, US John Mark Chandler - Bear DE, US
Assignee:
Croda, Inc. - Edison NJ
International Classification:
C08G 65/08
US Classification:
554213
Abstract:
A compound of the formulawhere: Ris the residue of a group having at least m active hydrogen atoms where m is at least 2; AO is an alkylene oxide residue; each n is independently from 0 to 100; and each Ris independently H or an acyl group CORwhere each Ris independently a residue of a polyhydroxyalkyl or polyhydroxyalkenyl carboxylic acid, a residue of a hydroxyalkyl or hydroxyalkenyl carboxylic acid and/or a residue of an oligomer of the hydroxyalkyl or hydroxyalkenyl carboxylic acid wherein on average at least 2 of Ris an acyl group. The compounds are particularly suitable for use as emulsifiers and/or dispersants.
- Brentford, Middlesex, GB Xin CHEN - Collegeville PA, US Rennan PAN - Collegeville PA, US
International Classification:
A61K 31/553 A61K 9/20 A61P 17/06
Abstract:
The present invention relates to modified release pharmaceutical compositions of a RIP1 kinase inhibitor compound and forms thereof, processes or methods of composition preparation and uses or treatment methods therefor.
Flame Retardant Composition Comprising A Polysiloxane
In an embodiment, a flame retardant composition comprises 60 to 95 wt % of a polycarbonate; a polysiloxane comprising a repeat unit of the formula (7); wherein the composition comprises 0.5 to 2 wt % of the repeat unit of the formula (7) of the polysiloxane; wherein the polysiloxane is free of one or both of a vinyl graft and repeat units derived from a vinyl monomer; 9 to 18 wt % of talc; 5 to 15 wt % of a phosphorus containing flame retardant; 0 to 1 wt % of a phosphite stabilizer; and 0.1 to 2 wt % of an anti-drip agent.
Cleaning Formulation Comprising A Solvent Additive
- Edison NJ, US Xin Chen - Hockessin DE, US Li Chen - Upper Chichester PA, US Mei-Ly Chua - Levittown PA, US Joseph William Scheblein - Flemington NJ, US Gregory Howard Smith - West Chester PA, US
A cleaning formulation has from 10 to 99 wt % water, from 0.8 to 40 wt % surfactant, optionally other additives, and from 0.2 to 20 wt % of a solvent additive of formula (I):where Ris Cto Calkyl, AO is an alkylene oxide group selected from an ethylene oxide group, a propylene oxide group and a butylene oxide group. At least one AO group in the solvent additive is an ethylene oxide group. The solvent additive has a water solubility of less than 1 wt % in deionised water at 20 C. and the surfactant enables the solvent additive to dissolve and/or disperse in the cleaning formulation. In a method of cleaning an oily or waxy soil from a hard surface, the solvent additive is applied to the hard surface and optionally rinsed with water. The solvent additive is used in a cleaning formulation to improve the percentage soil removal.
- Edison NJ, US Craig Michael Sungail - Chadds Ford PA, US Xin Chen - Hockessin DE, US
Assignee:
Croda, Inc. - Edison NJ
International Classification:
C11B 1/10 B01D 17/04 C11B 13/00 C12F 3/10
Abstract:
A method of separating oil from a composition containing an oil and water emulsion, by adding a separation additive which is a mixture of a fatty ester of an alkoxylated polyol and a fatty ester of alkoxylated glycerol, and performing at least one oil separation step. The method is particularly suitable for separating corn oil from stillage produced in a corn ethanol mill.
SCHOOL OF SOCIAL POLICY & PRACTICE AT UPENN Philadelphia, PA Oct 2013 to Jan 2014 Research AssistantMENELAOS TRIANTAFILLOU & ASSOCIATES Cincinnati, OH Dec 2012 to Apr 2013 Planning & GIS Analyst InternUNIVERSITY OF CINCINNATI - ARCHITECTURE OFFICE Cincinnati, OH Sep 2011 to Dec 2011 Architecture AssistantMEISNER + ASSOCIATE LAND VISION Cincinnati, OH Jun 2011 to Sep 2011 Planning & GIS Analyst InternXinjiang Province
Jun 2010 to Sep 2010 Architecture Assistant
Education:
UNIVERSITY OF PENNSYLVANIA - SCHOOL OF PENN DESIGN Philadelphia, PA May 2013 to Aug 2013 Master of ScienceUNIVERSITY OF CINCINNATI - COLLEGE OF DESIGN Cincinnati, OH Aug 2008 to Apr 2013 Bachelor of Art in Urban Planning
Sep 2014 to 2000 Store AssociateWorldwide Fabricating LTD Philadelphia, PA Jul 2011 to Sep 2014 Warehouse &Shipping CoordinatorQuizsno Bellevue, WA 2002 to 2003 Crew MemberMailroom Support Bellevue, WA 2001 to 2002Beijing Golden Vision Disc Ltd
1998 to 2000 Electrical Engineer
Education:
Centenary College Hackettstown, NJ May 2009 Master of Business AdministrationTsingHua University of China Dec 2007 Associate in Computer Programming EngineerAccounting Central University of Finance and Economics Jul 2007 Bachelor of Arts in Business Administration
2011 to 2000Connective Tissue Oncology Society (CTOS)
2011 to 2000Postdoctoral
2000 to 2000 Research AssociatePostdoctoral
2001 to Jan 2010Postdoctoral San Diego, CA 2010 to 2010Postdoctoral
2008 to 2008Postdoctoral
2006 to 2006Dennis JE Philadelphia, PA 2006 to 2006Postdoctoral
2005 to 2005Postdoctoral
2005 to 2005Washington Convention Washington, DC 2005 to 2005Washington Convention Washington, DC 2005 to 2005 DC, USA. Selected as a New Investigator Recognition Awards (NIRA) finalistPostdoctoral Bethesda, MD 2004 to 2004 New Investigator Recognition AwardsPostdoctoral
2004 to 2004Treatment of Osteoporosis Bethesda, MD 2004 to 2004EM. Lipopolysaccharide
2004 to 2004 Bone Miner ResPostdoctoral Minneapolis, MN 2003 to 2003USA. J Minneapolis, MN 2003 to 2003 Bone Miner Res13. Chen X, Dai JC, Orellana SA, and Greenfield
2003 to 2003 Miner ResASBMR San Antonio, TX 2002 to 2002 USA. J Bone Miner ResPTH and TNFalpha
2002 to 2002 Texas, USA. J Bone Miner ResASBMR Phoenix, AZ 2001 to 2001 USA. J Bone Miner ResDepartment of Biosignal Pathophysiology
1994 to 2000 Visiting Scientist and Graduate StudentKagojima, Japan Yokohama, JP 1997 to 1997Health Association
1996 to 1996Japan University Health Association, Nagano, Japan
1994 to 1994Department of Pathophysiology
1986 to 1993 Teaching Assistant and LecturerDepartment of Pathophysiology
1986 to 1993 Graduate Student and Research AssistantDepartment of Pathophysiology
1991 to 1991Department of Pathophysiology
1990 to 1990
Education:
Case Western Reserve University 2003 to 2000 Research AssociateSchool of Medicine 2000 to 2003Kobe University School of Medicine 1994 to 2000 Ph.D. in biosignal PathophysiologyChina Medical University and Bethune Medical University 1993 to 1994 English and Japanese TraineeHunan Medical University and Hengyang Medical College 1986 to 1989 Master's in PathophysiologyNorth China Coal Medical College 1981 to 1986 Doctor in MedicalSchool of Medicine, Case Western Reserve University
The next step is to investigate whether it is possible to develop a drug delivery system based on graphene oxide for Alzheimers disease, says Xin Chen. We also want to test whether graphene oxide has beneficial effects in additional models of neurodegenerative diseases, such as Parkinsons diseaReference: Graphene Oxide Attenuates Toxicity of Amyloid- Aggregates in Yeast by Promoting Disassembly and Boosting Cellular Stress Response by Xin Chen, Santosh Pandit, Lei Shi, Vaishnavi Ravikumar, Julie Bonne Khler, Ema Svetlicic, Zhejian Cao, Abhroop Garg, Dina Petranovic and Ivan Mijakovic,
Date: Oct 04, 2023
Category: Health
Source: Google
Cells Get a Makeover, Cancer Follows: A Path to New Therapies or Warning to ...
In this case, two young scientists, Holger Willenbring and Xin Chen, were trying to study a deadly, and fairly common, form of liver cancer called hepatocellular carcinoma. Chen and her group hoped to induce the cancer by activating oncogenes, genes that trigger cancer, in a group of liver cells cal
Although the components have each been reported before, "It is probably one of the first and best demonstrations of a combination of nanotechology, hydrogen-fuel technology and soft robotics," said Xin Chen of Boston University who was not a part of the study.
Columbia University - Computer Science, Zhejiang University - Information Science and Engineering
Xin Chen
Work:
Terminator skynet - Eliminator (2090-3015) Skynet
Education:
Sint-montfortcollege
Tagline:
I'm the chinese eliminator
Xin Chen
Work:
TrendSource - Marketing Associate (2011)
Education:
San Diego State University - Marketing, Grossmont College - Business Administration
Tagline:
Dream Flighter!
Xin Chen
Education:
Duke University - Master of Economics, Miami University - Business Economics
About:
Disciple of Love and Beauty.Defender of Rationality and Humanity.
Xin Chen
Work:
COMODO - QA Engineer (2009)
Education:
Beijing Jiaotong University - Electromagnetic Compatibility, Beijing Jiaotong University - Optics
Xin Chen
Education:
Pennsylvania State University - CSE, Nanjing University - CS, None
Xin Chen
Education:
Purdue University
About:
I am currently a PhD student in the School of Engineering Education at Purdue University. I have a BS in Electrical Engineering. My research focuses on Social Media Analytics in the context of enginee...
Bragging Rights:
I like cooking and beautiful food; I think friends are very important in life.